Erythropoietin	B-protein
stimulates	O
transcription	O
of	O
the	O
TAL1/SCL	B-DNA
gene	I-DNA
and	O
phosphorylation	O
of	O
its	O
protein	B-protein
products	I-protein
.	O

Activation	O
of	O
the	O
TAL1	B-DNA
(	I-DNA
or	I-DNA
SCL	I-DNA
)	I-DNA
gene	I-DNA
,	O
originally	O
identified	O
through	O
its	O
involvement	O
by	O
a	O
recurrent	O
chromosomal	O
translocation	O
,	O
is	O
the	O
most	O
frequent	O
molecular	O
lesion	O
recognized	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
.	O

The	O
protein	B-protein
products	I-protein
of	O
this	O
gene	O
contain	O
the	O
basic-helix-loop-helix	B-protein
motif	I-protein
characteristic	O
of	O
a	O
large	O
family	O
of	O
transcription	B-protein
factors	I-protein
that	O
bind	O
to	O
the	O
canonical	B-DNA
DNA	I-DNA
sequence	I-DNA
CANNTG	I-DNA
as	O
protein	B-protein
heterodimers	I-protein
.	O

TAL1	B-protein
expression	O
by	O
erythroid	B-cell_type
cells	I-cell_type
in	O
vivo	O
and	O
in	O
chemical-induced	B-cell_line
erythroleukemia	I-cell_line
cell	I-cell_line
lines	I-cell_line
in	O
vivo	O
suggested	O
the	O
gene	O
might	O
regulate	O
aspects	O
of	O
erythroid	O
differentiation	O
.	O

Since	O
the	O
terminal	O
events	O
of	O
erythropoiesis	O
are	O
controlled	O
by	O
the	O
glycoprotein	B-protein
hormone	I-protein
erythropoietin	I-protein
(	O
Epo	B-protein
)	O
,	O
we	O
investigated	O
whether	O
the	O
expression	O
or	O
activity	O
of	O
the	O
TAL1	B-DNA
gene	I-DNA
and	O
its	O
protein	B-protein
products	I-protein
were	O
affected	O
by	O
Epo	B-protein
in	O
splenic	B-cell_type
erythroblasts	I-cell_type
from	O
mice	O
infected	O
with	O
an	O
anemia-inducing	O
strain	O
of	O
Friend	O
virus	O
(	O
FVA	O
cells	O
)	O
.	O

Epo	B-protein
elicited	O
a	O
rapid	O
,	O
dose-related	O
increase	O
in	O
TAL1	B-RNA
mRNA	I-RNA
by	O
increasing	O
transcription	O
of	O
the	O
gene	O
and	O
stabilizing	O
one	O
of	O
its	O
mRNAs	B-RNA
.	O

An	O
Epo	B-protein
-inducible	O
TAL1	B-protein
DNA	O
binding	O
activity	O
was	O
identified	O
in	O
FVA	O
cell	O
nuclear	O
extracts	O
that	O
subsequently	O
decayed	O
despite	O
accumulating	O
mRNA	B-RNA
and	O
protein	O
.	O

Induction	O
of	O
DNA	O
binding	O
activity	O
was	O
associated	O
temporally	O
with	O
Epo	B-protein
-induced	O
phosphorylation	O
of	O
nuclear	B-protein
TAL1	I-protein
protein	I-protein
.	O

These	O
results	O
indicate	O
that	O
Epo	B-protein
acts	O
at	O
both	O
transcriptional	O
and	O
posttranscriptional	O
levels	O
on	O
the	O
TAL1	B-protein
locus	O
in	O
Friend	B-cell_line
virus-induced	I-cell_line
erythroblasts	I-cell_line
and	O
establish	O
a	O
link	O
between	O
Epo	B-protein
signaling	O
mechanisms	O
and	O
a	O
member	O
of	O
a	O
family	O
of	O
transcription	B-protein
factors	I-protein
involved	O
in	O
the	O
differentiation	O
of	O
diverse	B-cell_type
cell	I-cell_type
lineages	I-cell_type
.	O

TeE	NULL
Journat	NULL
or	NULL
BrorOGIcaL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

19	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
12	NULL
,	NULL
pp	NULL
.	NULL

11603-11611	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Erythropoietin	NULL
Stimulates	NULL
Transcription	NULL
of	NULL
the	NULL
TALI/SCL	NULL
Gene	NULL
and	NULL
Phosphorylation	NULL
of	NULL
Its	NULL
Protein	NULL
Products*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
8	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
23	NULL
,	NULL
1995	NULL
)	NULL
K.	NULL
S.	NULL
Srinivasa	NULL
Prasadt§	NULL
,	NULL
Jan	NULL
E.	NULL
Jordant	NULL
,	NULL
Mark	NULL
J.	NULL
Koury	NULL
#	NULL
1	NULL
,	NULL
Maurice	NULL
C.	NULL
Bondurant	NULL
?	NULL

1	NULL
,	NULL
and	NULL
Stephen	NULL
J.	NULL
Brandt	NULL
}	NULL
]	NULL
**	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Medicine	NULL
and	NULL
||Cell	NULL
Biology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
Medical	NULL
Center	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Center	NULL
,	NULL
Nashville	NULL
,	NULL
Tennessee	NULL
37232	NULL
Activation	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
(	NULL
or	NULL
SCL	NULL
)	NULL
gene	NULL
,	NULL
originally	NULL
identified	NULL
through	NULL
its	NULL
involvement	NULL
by	NULL
a	NULL
recurrent	NULL
chromosomal	NULL
translocation	NULL
,	NULL
is	NULL
the	NULL
most	NULL
frequent	NULL
molecular	NULL
lesion	NULL
recognized	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

The	NULL
protein	NULL
products	NULL
of	NULL
this	NULL
gene	NULL
contain	NULL
the	NULL
basic-helix-loop-helix	NULL
motif	NULL
characteristic	NULL
of	NULL
a	NULL
large	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
canonical	NULL
DNA	NULL
sequence	NULL
CANNTG	NULL
as	NULL
protein	NULL
heterodimers	NULL
.	NULL

TAL1	NULL
expression	NULL
by	NULL
erythroid	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
chemical-in-duced	NULL
erythroleukemia	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
suggested	NULL
the	NULL
gene	NULL
might	NULL
regulate	NULL
aspects	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Since	NULL
the	NULL
terminal	NULL
events	NULL
of	NULL
erythropoiesis	NULL
are	NULL
controlled	NULL
by	NULL
the	NULL
glycoprotein	NULL
hormone	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
expression	NULL
or	NULL
activity	NULL
of	NULL
the	NULL
TALLI	NULL
gene	NULL
and	NULL
its	NULL
protein	NULL
products	NULL
were	NULL
affected	NULL
by	NULL
Epo	NULL
in	NULL
splenic	NULL
erythroblasts	NULL
from	NULL
mice	NULL
infected	NULL
with	NULL
an	NULL
anemia-inducing	NULL
strain	NULL
of	NULL
Friend	NULL
virus	NULL
(	NULL
FVA	NULL
cells	NULL
)	NULL
.	NULL

Epo	NULL
elicited	NULL
a	NULL
rapid	NULL
,	NULL
dose-related	NULL
increase	NULL
in	NULL
TALL	NULL
mRNA	NULL
by	NULL
increasing	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
stabilizing	NULL
one	NULL
of	NULL
its	NULL
mRNAs	NULL
.	NULL

An	NULL
Epo-inducible	NULL
TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
identified	NULL
in	NULL
FVA	NULL
cell	NULL
nuclear	NULL
extracts	NULL
that	NULL
subsequently	NULL
decayed	NULL
despite	NULL
accumulating	NULL
mRNA	NULL
and	NULL
protein	NULL
.	NULL

Induction	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
associated	NULL
temporally	NULL
with	NULL
Epo-induced	NULL
phosphorylation	NULL
of	NULL
nuclear	NULL
TALl	NULL
protein	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Epo	NULL
acts	NULL
at	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
levels	NULL
on	NULL
the	NULL
TAL	NULL
1	NULL
locus	NULL
in	NULL
Friend	NULL
virus-induced	NULL
erythroblasts	NULL
and	NULL
establish	NULL
a	NULL
link	NULL
between	NULL
Epo	NULL
signaling	NULL
mechanisms	NULL
and	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
diverse	NULL
cell	NULL
lineages	NULL
.	NULL

The	NULL
TAL1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
SCL	NULL
and	NULL
TCLS5	NULL
)	NULL
gene	NULL
was	NULL
originally	NULL
identified	NULL
through	NULL
its	NULL
location	NULL
at	NULL
a	NULL
chromosome	NULL
break-point	NULL
in	NULL
patients	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Although	NULL
involved	NULL
in	NULL
reciprocal	NULL
translocations	NULL
with	NULL
the	NULL
T-cell	NULL
receptor-a/8	NULL
and	NULL
,	NULL
in	NULL
one	NULL
case	NULL
,	NULL
-8	NULL
locus	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
gene	NULL
is	NULL
more	NULL
frequently	NULL
affected	NULL
by	NULL
interstitial	NULL
deletions	NULL
upstream	NULL
of	NULL
its	NULL
coding	NULL
region	NULL
which	NULL
result	NULL
in	NULL
the	NULL
head-to-tail	NULL
fusion	NULL
of	NULL
the	NULL
TAL1	NULL
and	NULL
SIL	NULL
(	NULL
for	NULL
SCL	NULL
interrupting	NULL
locus	NULL
)	NULL
genes	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

These	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
R29	NULL
HL49118	NULL
(	NULL
to	NULL
S.	NULL
J	NULL
.	NULL

B	NULL
.	NULL
)	NULL

and	NULL
RO1	NULL
DK31513	NULL
(	NULL
to	NULL
M.	NULL
J.	NULL
K.	NULL
)	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Veterans	NULL
Affairs	NULL
(	NULL
to	NULL
M.	NULL
C	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Life	NULL
and	NULL
Health	NULL
Insurance	NULL
Medical	NULL
Research	NULL
Fund	NULL
(	NULL
to	NULL
S.	NULL
J	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Charitable	NULL
Trust	NULL
(	NULL
to	NULL
S.	NULL
J	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
Ortho	NULL
Biotech	NULL
(	NULL
to	NULL
K.	NULL
S.	NULL
S.	NULL
P.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Ortho	NULL
Biotech	NULL
Hematology	NULL
Fellow	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Div	NULL
.	NULL

of	NULL
Hematology	NULL
,	NULL
Rm	NULL
.	NULL

547	NULL
MRB	NULL
II	NULL
,	NULL
Vanderbilt	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
615-936-1809	NULL
;	NULL
Fax	NULL
:	NULL
615-986-1812.	NULL
chromosomal	NULL
abnormalities	NULL
do	NULL
not	NULL
generally	NULL
alter	NULL
the	NULL
gene	NULL
's	NULL
coding	NULL
potential	NULL
and	NULL
likely	NULL
contribute	NULL
to	NULL
leukemogenesis	NULL
through	NULL
inappropriate	NULL
expression	NULL
of	NULL
the	NULL
rearranged	NULL
allele	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
deregulated	NULL
TAL	NULL
7	NULL
expression	NULL
may	NULL
occur	NULL
in	NULL
as	NULL
many	NULL
as	NULL
30	NULL
%	NULL
of	NULL
individuals	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
,	NULL
making	NULL
this	NULL
the	NULL
most	NULL
frequent	NULL
molecular	NULL
lesion	NULL
recognized	NULL
in	NULL
this	NULL
disorder	NULL
.	NULL

The	NULL
protein	NULL
products	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
contain	NULL
a	NULL
dimerization	NULL
motif	NULL
characteristic	NULL
of	NULL
a	NULL
large	NULL
family	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
fate	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

This	NULL
conserved	NULL
domain	NULL
was	NULL
predicted	NULL
to	NULL
adopt	NULL
a	NULL
helix-loop-helix	NULL
(	NULL
HLH	NULL
)	NULL
conformation	NULL
in	NULL
which	NULL
two	NULL
amphipathic	NULL
helices	NULL
are	NULL
separated	NULL
by	NULL
a	NULL
less	NULL
structured	NULL
loop	NULL
region	NULL
of	NULL
varying	NULL
length	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
HLH	NULL
motif	NULL
promotes	NULL
the	NULL
formation	NULL
of	NULL
protein	NULL
hetero-	NULL
and	NULL
homodimers	NULL
,	NULL
while	NULL
an	NULL
adjacent	NULL
region	NULL
enriched	NULL
in	NULL
basic	NULL
amino	NULL
acids	NULL
and	NULL
found	NULL
in	NULL
many	NULL
of	NULL
the	NULL
proteins	NULL
of	NULL
this	NULL
class	NULL
mediates	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

The	NULL
basic	NULL
domain-HLH	NULL
(	NULL
bHLH	NULL
)	NULL
proteins	NULL
,	NULL
including	NULL
TAL1	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
,	NULL
bind	NULL
as	NULL
dimers	NULL
to	NULL
a	NULL
canonical	NULL
sequence	NULL
CANNTG	NULL
termed	NULL
the	NULL
E-box	NULL
and	NULL
function	NULL
as	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Distinct	NULL
subgroups	NULL
of	NULL
HLH	NULL
genes	NULL
can	NULL
be	NULL
recognized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
sequence	NULL
homology	NULL
,	NULL
pattern	NULL
of	NULL
expression	NULL
,	NULL
and	NULL
function	NULL
.	NULL

Four	NULL
bHLH	NULL
proteins	NULL
,	NULL
of	NULL
which	NULL
MyoD	NULL
is	NULL
the	NULL
prototype	NULL
,	NULL
are	NULL
expressed	NULL
in	NULL
developing	NULL
muscle	NULL
and	NULL
share	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
myogenic	NULL
differentiation	NULL
when	NULL
expressed	NULL
in	NULL
certain	NULL
cell	NULL
lines	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
three	NULL
genes	NULL
TAL1	NULL
,	NULL
TAL2	NULL
,	NULL
and	NULL
LYL-1	NULL
show	NULL
greater	NULL
than	NULL
80	NULL
%	NULL
identity	NULL
within	NULL
their	NULL
basic	NULL
and	NULL
HLH	NULL
domains	NULL
and	NULL
share	NULL
an	NULL
additional	NULL
similarity	NULL
in	NULL
that	NULL
each	NULL
was	NULL
isolated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
its	NULL
involvement	NULL
in	NULL
a	NULL
human	NULL
leukemia	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
recently	NULL
identified	NULL
bHLH-EC2	NULL
gene	NULL
also	NULL
shows	NULL
considerable	NULL
sequence	NULL
homology	NULL
to	NULL
and	NULL
overlaps	NULL
with	NULL
TAL	NULL
]	NULL
in	NULL
its	NULL
expression	NULL
(	NULL
20	NULL
)	NULL
.	NULL

TAL1	NULL
RNA	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
megakaryocytic	NULL
,	NULL
erythroid	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
lines	NULL
(	NULL
21-23	NULL
)	NULL
and	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
in	NULL
human	NULL
megakaryocytes	NULL
,	NULL
erythroblasts	NULL
,	NULL
and	NULL
basophilic	NULL
granulocytes	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Endothelial	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
and	NULL
neurons	NULL
(	NULL
23	NULL
)	NULL
have	NULL
also	NULL
been	NULL
found	NULL
to	NULL
express	NULL
TAL1	NULL
RNA	NULL
and	NULL
protein	NULL
,	NULL
and	NULL
studies	NULL
of	NULL
its	NULL
expression	NULL
during	NULL
embryogenesis	NULL
suggest	NULL
the	NULL
gene	NULL
may	NULL
have	NULL
actions	NULL
in	NULL
vascular	NULL
,	NULL
neural	NULL
,	NULL
and	NULL
hematopoietic	NULL
development	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Considerable	NULL
evidence	NULL
suggests	NULL
that	NULL
TAL	NULL
I	NULL
regulates	NULL
aspects	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

TALI	NULL
RNA	NULL
and	NULL
protein	NULL
are	NULL
expressed	NULL
in	NULL
embryonic	NULL
and	NULL
adult	NULL
erythroid	NULL
progenitors	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
26	NULL
)	NULL
and	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cell	NULL
lines	NULL
,	NULL
increasing	NULL
significantly	NULL
with	NULL
hexamethylene	NULL
bisacetamide-	NULL
or	NULL
Me	NULL
,	NULL
SO-in-duced	NULL
differentiation	NULL
(	NULL
21	NULL
,	NULL
22	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
enforced	NULL
expression	NULL
of	NULL
TALI	NULL
promotes	NULL
the	NULL
differentiation	NULL
of	NULL
MEL	NULL
lines	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
chemical	NULL
inducer	NULL
,	NULL
while	NULL
antisense-me-diated	NULL
inhibition	NULL
of	NULL
TALI	NULL
expression	NULL
blocks	NULL
Me	NULL
,	NULL
SO-	NULL
and	NULL
hexa-	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HLH	NULL
,	NULL
helix-loop-helix	NULL
;	NULL
bHLH	NULL
,	NULL
basic	NULL
domain	NULL
helix-loop-helix	NULL
;	NULL
MEL	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
;	NULL
Epo	NULL
,	NULL
erythropoie-tin	NULL
;	NULL
FVA	NULL
,	NULL
anemia-inducing	NULL
strain	NULL
of	NULL
Friend	NULL
virus	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
EpoR	NULL
,	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

11603	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
papeojumo	NULL
(	NULL
11604	NULL
methylene	NULL
bisacetamide-stimulated	NULL
differentiation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
terminal	NULL
events	NULL
of	NULL
erythropoiesis	NULL
are	NULL
controlled	NULL
by	NULL
the	NULL
glycoprotein	NULL
hormone	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
,	NULL
these	NULL
observations	NULL
suggested	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TAL	NULL
1	NULL
gene	NULL
or	NULL
the	NULL
activity	NULL
of	NULL
its	NULL
protein	NULL
products	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
this	NULL
growth	NULL
factor	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
effects	NULL
of	NULL
Epo	NULL
on	NULL
TALI	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
we	NULL
have	NULL
used	NULL
erythroblasts	NULL
purified	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
mice	NULL
infected	NULL
with	NULL
an	NULL
anemia-inducing	NULL
strain	NULL
of	NULL
Friend	NULL
virus	NULL
(	NULL
FVA	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
established	NULL
MEL	NULL
lines	NULL
,	NULL
these	NULL
cells	NULL
show	NULL
an	NULL
absolute	NULL
dependence	NULL
on	NULL
Epo	NULL
for	NULL
their	NULL
initial	NULL
survival	NULL
in	NULL
culture	NULL
and	NULL
undergo	NULL
apoptosis	NULL
if	NULL
the	NULL
growth	NULL
factor	NULL
is	NULL
withheld	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
Epo	NULL
,	NULL
FVA	NULL
cells	NULL
complete	NULL
a	NULL
full	NULL
program	NULL
of	NULL
differentiation	NULL
over	NULL
a	NULL
period	NULL
of	NULL
48-60	NULL
h	NULL
,	NULL
including	NULL
nuclear	NULL
extrusion	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
reticulocytes	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
cell	NULL
system	NULL
has	NULL
been	NULL
extensively	NULL
characterized	NULL
with	NULL
regard	NULL
to	NULL
Epo	NULL
's	NULL
effects	NULL
on	NULL
hemoglobin	NULL
synthesis	NULL
(	NULL
30	NULL
)	NULL
,	NULL
cytoskeletal	NULL
maturation	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
represents	NULL
an	NULL
excellent	NULL
model	NULL
of	NULL
normal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Our	NULL
experiments	NULL
indicate	NULL
that	NULL
sequential	NULL
activating	NULL
and	NULL
inhibitory	NULL
influ-ences	NULL
,	NULL
operating	NULL
at	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcrip-tional	NULL
levels	NULL
,	NULL
act	NULL
on	NULL
the	NULL
TALI	NULL
locus	NULL
in	NULL
Epo-stimulated	NULL
erythroblasts	NULL
.	NULL

Furthermore	NULL
,	NULL
they	NULL
establish	NULL
a	NULL
link	NULL
between	NULL
signaling	NULL
by	NULL
this	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
and	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
many	NULL
of	NULL
whose	NULL
members	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
specify	NULL
cell	NULL
fate	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-CD	NULL
,	NULL
F	NULL
,	NULL
mice	NULL
of	NULL
8-12	NULL
weeks	NULL
of	NULL
age	NULL
were	NULL
given	NULL
10°	NULL
spleen	NULL
focus-forming	NULL
units	NULL
of	NULL
an	NULL
anemia-inducing	NULL
strain	NULL
of	NULL
Friend	NULL
virus	NULL
by	NULL
tail	NULL
vein	NULL
injection	NULL
.	NULL

The	NULL
animals	NULL
were	NULL
sacrificed	NULL
2	NULL
weeks	NULL
later	NULL
and	NULL
erythroblasts	NULL
purified	NULL
from	NULL
spleen	NULL
cell	NULL
suspensions	NULL
by	NULL
sedimentation	NULL
at	NULL
unit	NULL
gravity	NULL
through	NULL
a	NULL
linear	NULL
gradient	NULL
of	NULL
1	NULL
to	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

FVA-induced	NULL
erythroblasts	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
30	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
1	NULL
%	NULL
deionized	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
«	NULL
-thioglycerol	NULL
with	NULL
the	NULL
indicated	NULL
concentration	NULL
of	NULL
recombinant	NULL
human	NULL
Epo	NULL
(	NULL
Ortho	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
of	NULL
culture	NULL
and	NULL
washed	NULL
once	NULL
with	NULL
chilled	NULL
phosphate-buffered	NULL
saline	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
erythroblasts	NULL
using	NULL
a	NULL
single	NULL
step	NULL
guanidine	NULL
thiocyanate/phenol	NULL
method	NULL
(	NULL
RNAzol	NULL
;	NULL
BicTecx	NULL
)	NULL
(	NULL
32	NULL
)	NULL
.	NULL

RNA	NULL
samples	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
0.66	NULL
M	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
by	NULL
capillary	NULL
action	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Nytran	NULL
;	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
)	NULL
.	NULL

Baked	NULL
membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
4-6	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
x	NULL
SSC	NULL
(	NULL
1	NULL
x	NULL
=	NULL
0.15	NULL
m	NULL
NaCl	NULL
,	NULL
0.015	NULL
m	NULL
sodium	NULL
citrate	NULL
)	NULL
,	NULL
1	NULL
X	NULL
Denhardt	NULL
's	NULL
solution	NULL
(	NULL
0.02	NULL
%	NULL
Ficoll	NULL
,	NULL
0.02	NULL
%	NULL
polyvi-nylpyrrolidone	NULL
,	NULL
0.02	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
and	NULL
100	NULL
pg/ml	NULL
denatured	NULL
herring	NULL
sperm	NULL
DNA	NULL
.	NULL

Blots	NULL
were	NULL
hybridized	NULL
overnight	NULL
at	NULL
42	NULL
°C	NULL
with	NULL
1.5	NULL
X	NULL
10°	NULL
cpm/ml	NULL
radiolabeled	NULL
probe	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
and	NULL
washed	NULL
with	NULL
2	NULL
x	NULL
SSC	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
for	NULL
1	NULL
h	NULL
at	NULL
65	NULL
°C	NULL
,	NULL
and	NULL
0.1	NULL
x	NULL
SSC	NULL
for	NULL
30	NULL
min	NULL
at	NULL
65	NULL
°C	NULL
.	NULL

Following	NULL
washing	NULL
,	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
and	NULL
the	NULL
resulting	NULL
autoradiograms	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
.	NULL

RNA	NULL
loading	NULL
was	NULL
normalized	NULL
to	NULL
28	NULL
S	NULL
ribosomal	NULL
RNA	NULL
using	NULL
a	NULL
photographic	NULL
negative	NULL
of	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
gel	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
Data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
were	NULL
used	NULL
in	NULL
determining	NULL
the	NULL
mean	NULL
RNA	NULL
level	NULL
+8.E	NULL
.	NULL

for	NULL
both	NULL
the	NULL
5.0-	NULL
and	NULL
3.7-kb	NULL
TALZ	NULL
mRNAs	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
following	NULL
Epo	NULL
addition	NULL
.	NULL

Differences	NULL
in	NULL
mean	NULL
RNA	NULL
levels	NULL
in	NULL
Epo-treated	NULL
versus	NULL
Epo-deprived	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
two-tailed	NULL
?	NULL

test	NULL
.	NULL

A	NULL
535-base	NULL
pair	NULL
Banl/Xbal	NULL
restriction	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
TALLI	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
.	NULL

This	NULL
region	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
conserved	NULL
basic	NULL
and	NULL
HLH	NULL
domains	NULL
to	NULL
avoid	NULL
potential	NULL
cross-hybridization	NULL
to	NULL
related	NULL
HLH	NULL
sequences	NULL
.	NULL

The	NULL
GATA-1	NULL
probe	NULL
was	NULL
an	NULL
XAo	NULL
!	NULL

/Xhol	NULL
restriction	NULL
fragment	NULL
of	NULL
plasmid	NULL
pXM-GF-1	NULL
containing	NULL
the	NULL
full	NULL
coding	NULL
sequence	NULL
of	NULL
murine	NULL
GATA-1	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
Id1	NULL
probe	NULL
was	NULL
a	NULL
BamHUEcoRI	NULL
restriction	NULL
fragment	NULL
of	NULL
plasmid	NULL
pMH18AR	NULL
containing	NULL
bases	NULL
5-927	NULL
of	NULL
murine	NULL
Id1	NULL
sequence	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
the	NULL
LYL-1	NULL
probe	NULL
was	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction-generated	NULL
cDNA	NULL
containing	NULL
bases	NULL
-28-422	NULL
of	NULL
murine	NULL
LYL-I	NULL
sequence	NULL
(	NULL
22	NULL
)	NULL
.	NULL

All	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
by	NULL
random	NULL
primer	NULL
extension	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Nuclear	NULL
Run-off	NULL
Analysis-Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
FVA-induced	NULL
erythroblasts	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
using	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
and	NULL
frozen	NULL
overnight	NULL
at	NULL
-70	NULL
°C	NULL
in	NULL
a	NULL
buffer	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
containing	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
37	NULL
)	NULL
using	NULL
5	NULL
xX	NULL
10	NULL
``	NULL
nuclei	NULL
and	NULL
250	NULL
Ci	NULL
of	NULL
[	NULL
a-*°P	NULL
]	NULL
JUTP	NULL
per	NULL
reaction	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
resulting	NULL
radiolabeled	NULL
RNA	NULL
was	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
and	NULL
proteinase	NULL
K	NULL
,	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
,	NULL
precipitated	NULL
with	NULL
trichloroacetic	NULL
acid	NULL
and	NULL
ethanol	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
diethylpyrocarbon-ate-treated	NULL
water	NULL
.	NULL

Nitrocellulose	NULL
filters	NULL
containing	NULL
the	NULL
indicated	NULL
probes	NULL
immobilized	NULL
by	NULL
baking	NULL
were	NULL
prehybridized	NULL
for	NULL
at	NULL
least	NULL
4	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
x	NULL
SSC	NULL
,	NULL
10	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
0.05	NULL
mg/ml	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
0.25	NULL
mg/m	NULL
]	NULL
herring	NULL
sperm	NULL
DNA	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
radiolabeled	NULL
RNA	NULL
adjusted	NULL
to	NULL
give	NULL
an	NULL
equal	NULL
number	NULL
of	NULL
counts	NULL
per	NULL
filter	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
96	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
and	NULL
filters	NULL
washed	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
for	NULL
70	NULL
min	NULL
at	NULL
42	NULL
°C	NULL
with	NULL
three	NULL
changes	NULL
.	NULL

The	NULL
identical	NULL
TALI	NULL
cDNA	NULL
probe	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
hybridization	NULL
was	NULL
used	NULL
in	NULL
nuclear	NULL
run-off	NULL
assays	NULL
.	NULL

The	NULL
actin	NULL
probe	NULL
was	NULL
a	NULL
PstVPstl	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
actin	NULL
clone	NULL
PAMQ1	NULL
containing	NULL
the	NULL
entire	NULL
«	NULL
-actin	NULL
coding	NULL
region	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Washed	NULL
filters	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
and	NULL
the	NULL
resulting	NULL
autoradiograms	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
.	NULL

Binding	NULL
of	NULL
radiolabeled	NULL
RNA	NULL
to	NULL
immobilized	NULL
plasmid	NULL
(	NULL
pGEM-42Z	NULL
)	NULL
carried	NULL
out	NULL
in	NULL
parallel	NULL
was	NULL
minimal	NULL
and	NULL
not	NULL
included	NULL
in	NULL
data	NULL
analysis	NULL
.	NULL

Data	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
mean	NULL
fold	NULL
increase	NULL
in	NULL
transcriptional	NULL
rate	NULL
+	NULL
S.E	NULL
.	NULL

as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
following	NULL
Epo	NULL
addition	NULL
.	NULL

Differences	NULL
from	NULL
that	NULL
at	NULL
initiation	NULL
of	NULL
culture	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
two-tailed	NULL
£	NULL
test	NULL
.	NULL

RNA	NULL
Stability	NULL
Analysis-Cultures	NULL
of	NULL
FVA	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
or	NULL
without	NULL
2	NULL
units/ml	NULL
recombinant	NULL
Epo	NULL
,	NULL
following	NULL
which	NULL
actinomycin	NULL
D	NULL
was	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
5	NULL
ug/ml	NULL
.	NULL

Previous	NULL
studies	NULL
established	NULL
that	NULL
this	NULL
concentration	NULL
of	NULL
actinomycin	NULL
D	NULL
was	NULL
sufficient	NULL
to	NULL
inhibit	NULL
transcription	NULL
in	NULL
FVA	NULL
cells	NULL
without	NULL
significant	NULL
toxicity	NULL
during	NULL
the	NULL
period	NULL
analyzed	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
at	NULL
30	NULL
min	NULL
intervals	NULL
for	NULL
up	NULL
to	NULL
3	NULL
h	NULL
following	NULL
actinomycin	NULL
D	NULL
treatment	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
as	NULL
described	NULL
.	NULL

The	NULL
resulting	NULL
autoradiograms	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
percentage	NULL
of	NULL
initial	NULL
mRNA	NULL
remaining	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
four	NULL
independent	NULL
experiments	NULL
was	NULL
expressed	NULL
for	NULL
both	NULL
Epo-treated	NULL
and	NULL
Epo-deprived	NULL
cells	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
following	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
to	NULL
culture	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Linear	NULL
regression	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
best	NULL
fit	NULL
of	NULL
the	NULL
line	NULL
for	NULL
log	NULL
transformed	NULL
data	NULL
and	NULL
95	NULL
%	NULL
confidence	NULL
intervals	NULL
determined	NULL
for	NULL
slopes	NULL
.	NULL

Immunoblot	NULL
Analysis-Affinity-purified	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
in	NULL
rabbits	NULL
against	NULL
a	NULL
bacterial	NULL
expressed	NULL
malE-fusion	NULL
containing	NULL
the	NULL
72	NULL
carboxyl-terminal	NULL
amino	NULL
acids	NULL
of	NULL
murine	NULL
TAL1	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Total	NULL
immunoglobulin	NULL
was	NULL
purified	NULL
from	NULL
serum	NULL
obtained	NULL
prior	NULL
to	NULL
immunization	NULL
on	NULL
protein	NULL
A-Sepharose	NULL
and	NULL
used	NULL
at	NULL
an	NULL
equivalent	NULL
concentration	NULL
where	NULL
indicated	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
39	NULL
)	NULL
of	NULL
FVA	NULL
cell	NULL
nuclear	NULL
protein	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
were	NULL
fractionated	NULL
on	NULL
gradient	NULL
(	NULL
8-15	NULL
%	NULL
)	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Membranes	NULL
were	NULL
probed	NULL
with	NULL
antibody	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
and	NULL
binding	NULL
detected	NULL
by	NULL
enhanced	NULL
chemilu-minescence	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

Autoradiograms	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
,	NULL
and	NULL
data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
were	NULL
used	NULL
in	NULL
determining	NULL
the	NULL
mean	NULL
TAL1	NULL
protein	NULL
level	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
following	NULL
Epo	NULL
addition	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
TAL1	NULL
protein	NULL
levels	NULL
in	NULL
Epo-treated	NULL
versus	NULL
Epo-deprived	NULL
cultures	NULL
was	NULL
determined	NULL
at	NULL
each	NULL
time	NULL
point	NULL
and	NULL
differences	NULL
from	NULL
that	NULL
at	NULL
initiation	NULL
of	NULL
culture	NULL
,	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
,	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
two-tailed	NULL
?	NULL

test	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Analysis-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
FVA	NULL
cells	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
with	NULL
slight	NULL
modification	NULL
.	NULL

Washed	NULL
FVA	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
a	NULL
chilled	NULL
buffer	NULL
containing	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mx	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
EGTA	NULL
,	NULL
5	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
5	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
mx	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
and	NULL
nuclei	NULL
isolated	NULL
with	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
,	NULL
Nuclei	NULL
were	NULL
centrifuged	NULL
at	NULL
12,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
,	NULL
washed	NULL
once	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
chilled	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
420	NULL
mm	NULL
KCI	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mm	NULL
EGTA	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
containing	NULL
50	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
25	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
sodium	NULL
vanadate	NULL
.	NULL

The	NULL
resulting	NULL
extracts	NULL
were	NULL
stirred	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
,	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
28,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-70	NULL
°C	NULL
until	NULL
used	NULL
.	NULL

Double	NULL
stranded	NULL
oligonucleotides	NULL
of	NULL
the	NULL
indicated	NULL
sequences	NULL
were	NULL
end-labeled	NULL
with	NULL
*°P	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
diluted	NULL
in	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mx	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
mx	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
with	NULL
or	NULL
without	NULL
the	NULL
indicated	NULL
antibodies	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
containing	NULL
2.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
60	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
100	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
in	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
papeojumo	NULL
(	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
tos	NULL
a	NULL
#	NULL
#	NULL
oe	NULL
o	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
mRNA	NULL
levels	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

Purified	NULL
splenic	NULL
erythroblasts	NULL
from	NULL
FVA-infected	NULL
mice	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
h.	NULL
Lane	NULL
marked	NULL
0	NULL
represents	NULL
cells	NULL
taken	NULL
prior	NULL
to	NULL
culture	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
``	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
0.8	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
murine	NULL
TALI	NULL
cDNA	NULL
probe	NULL
.	NULL

Autoradiogram	NULL
of	NULL
representative	NULL
Northern	NULL
blot	NULL
is	NULL
shown	NULL
in	NULL
upper	NULL
panel	NULL
.	NULL

Photograph	NULL
of	NULL
corresponding	NULL
ethidium	NULL
bromide-stained	NULL
gel	NULL
is	NULL
shown	NULL
in	NULL
lower	NULL
panel	NULL
.	NULL

a	NULL
total	NULL
volume	NULL
of	NULL
30	NULL
wl	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
using	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
upper	NULL
strand	NULL
of	NULL
each	NULL
pair	NULL
of	NULL
oligonucleotides	NULL
with	NULL
the	NULL
E-box	NULL
sequences	NULL
underlined	NULL
are	NULL
:	NULL
B2	NULL
,	NULL
CCTGCAGCAGCTG-GCAGGAA	NULL
;	NULL
mutant	NULL
E2	NULL
,	NULL
CCTGCAGCCGCTTGCAGGAA	NULL
;	NULL
preferred	NULL
site	NULL
,	NULL
ACCTGAACAGATGGTCGGCT	NULL
;	NULL
mutant	NULL
preferred	NULL
site	NULL
,	NULL
ACCT-GAACCGATTGTCGGCT	NULL
.	NULL

In	NULL
Vivo	NULL
Labeling	NULL
and	NULL
Immunoprecipitation	NULL
Analysis-Erythroblasts	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
phosphate-free	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
20	NULL
%	NULL
dialyzed	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
cultured	NULL
at	NULL
a	NULL
density	NULL
of	NULL
4	NULL
X	NULL
10°/ml	NULL
in	NULL
medium	NULL
containing	NULL
0.9	NULL
mCi/ml	NULL
[	NULL
*P	NULL
Jorthophosphate	NULL
(	NULL
ICN	NULL
Biomedicals	NULL
)	NULL
with	NULL
and	NULL
without	NULL
Epo	NULL
(	NULL
5	NULL
units/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Following	NULL
labeling	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Volumes	NULL
of	NULL
extract	NULL
containing	NULL
an	NULL
equivalent	NULL
number	NULL
of	NULL
trichloroacetic	NULL
acid-precipitable	NULL
counts	NULL
were	NULL
diluted	NULL
in	NULL
1	NULL
mi	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
EGTA	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
5	NULL
ug/ml	NULL
aprotinin	NULL
to	NULL
which	NULL
antibody	NULL
(	NULL
1:1000	NULL
)	NULL
or	NULL
preimmune	NULL
immunoglobulin	NULL
was	NULL
added	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
rocked	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
4	NULL
h	NULL
and	NULL
antigen-antibody	NULL
complexes	NULL
isolated	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
SDS-polyacrylamide	NULL
loading	NULL
buffer	NULL
,	NULL
and	NULL
resolved	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Epo	NULL
Induces	NULL
an	NULL
Increase	NULL
in	NULL
Steady	NULL
State	NULL
TAL1	NULL
mRNA	NULL
Levels	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-Incubation	NULL
of	NULL
FVA	NULL
cells	NULL
with	NULL
recombinant	NULL
Epo	NULL
resulted	NULL
in	NULL
proportional	NULL
increases	NULL
in	NULL
the	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
both	NULL
the	NULL
5.0-	NULL
and	NULL
3.7-kb	NULL
TALI	NULL
mRNAs	NULL
within	NULL
30	NULL
min	NULL
of	NULL
growth	NULL
factor	NULL
addition	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
maximum	NULL
stimulated	NULL
level	NULL
was	NULL
observed	NULL
at	NULL
2	NULL
h	NULL
,	NULL
with	NULL
a	NULL
mean	NULL
increase	NULL
after	NULL
correction	NULL
for	NULL
RNA	NULL
loading	NULL
of	NULL
3.5-	NULL
and	NULL
3.0-fold	NULL
for	NULL
the	NULL
larger	NULL
and	NULL
smaller	NULL
species	NULL
,	NULL
respectively	NULL
,	NULL
relative	NULL
to	NULL
that	NULL
measured	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
dose-dependent	NULL
increase	NULL
in	NULL
TALI	NULL
mRNA	NULL
was	NULL
noted	NULL
over	NULL
the	NULL
range	NULL
of	NULL
Epo	NULL
concentrations	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
anemia	NULL
(	NULL
0.16-2	NULL
units/	NULL
ml	NULL
)	NULL
,	NULL
with	NULL
near-maximal	NULL
responses	NULL
obtained	NULL
at	NULL
concentrations	NULL
greater	NULL
than	NULL
1	NULL
unit/ml	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Message	NULL
was	NULL
detected	NULL
for	NULL
at	NULL
least	NULL
72	NULL
h	NULL
following	NULL
Epo	NULL
addition	NULL
.	NULL

TAL1	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
erythroblasts	NULL
prior	NULL
to	NULL
culture	NULL
and	NULL
was	NULL
maintained	NULL
at	NULL
similar	NULL
levels	NULL
for	NULL
up	NULL
to	NULL
4	NULL
h	NULL
in	NULL
cultures	NULL
without	NULL
added	NULL
growth	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
propensity	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
undergo	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Epo	NULL
(	NULL
28	NULL
)	NULL
precluded	NULL
their	NULL
being	NULL
cultured	NULL
under	NULL
these	NULL
conditions	NULL
for	NULL
longer	NULL
periods	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
TAL1	NULL
message	NULL
observed	NULL
in	NULL
Epo-treated	NULL
FVA	NULL
cell	NULL
cultures	NULL
did	NULL
not	NULL
reflect	NULL
a	NULL
general	NULL
change	NULL
in	NULL
RNAs	NULL
encoding	NULL
transcription	NULL
factors	NULL
.	NULL

Steady	NULL
state	NULL
levels	NULL
of	NULL
mRNA	NULL
for	NULL
GATA-1	NULL
,	NULL
expressed	NULL
in	NULL
many	NULL
of	NULL
the	NULL
same	NULL
cell	NULL
types	NULL
as	NULL
TALI	NULL
,	NULL
did	NULL
not	NULL
11605	NULL
+Epo	NULL
©	NULL
5.0	NULL
kb	NULL
4	NULL
-	NULL
E	NULL
3.7	NULL
kb	NULL
-Epo	NULL
O	NULL
5.0	NULL
kb	NULL
03.7	NULL
kb	NULL
Fold	NULL
increase	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
TAL1	NULL
mRNA	NULL
accumulation	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
FVA	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
BBI	NULL
,	NULL
@	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
C	NULL
)	NULL
,	NULL
O	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Autoradiograms	NULL
of	NULL
hybridized	NULL
filters	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
.	NULL

Mean	NULL
induction	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
four	NULL
independent	NULL
experiments	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
in	NULL
h	NULL
after	NULL
Epo	NULL
addition	NULL
for	NULL
the	NULL
5.0-kb	NULL
(	NULL
0	NULL
,	NULL
@	NULL
)	NULL
and	NULL
3.7-kb	NULL
(	NULL
C	NULL
,	NULL
®	NULL
)	NULL
TALI	NULL
mRNAs	NULL
.	NULL

The	NULL
statistical	NULL
significance	NULL
of	NULL
differences	NULL
in	NULL
induction	NULL
between	NULL
Epo-treated	NULL
and	NULL
Epo-deprived	NULL
cells	NULL
is	NULL
denoted	NULL
by	NULL
the	NULL
symbols	NULL
,	NULL
*	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
**	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

increase	NULL
for	NULL
at	NULL
least	NULL
2-4	NULL
h	NULL
of	NULL
culture	NULL
and	NULL
that	NULL
of	NULL
the	NULL
related	NULL
HLH	NULL
gene	NULL
LYL-1	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
Epo	NULL
addition	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Epo	NULL
Stimulates	NULL
Transcription	NULL
of	NULL
the	NULL
TAL1	NULL
Gene	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-The	NULL
effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
transcription	NULL
was	NULL
analyzed	NULL
in	NULL
nuclear	NULL
run-off	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
was	NULL
detected	NULL
in	NULL
FVA	NULL
cells	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
culture	NULL
.	NULL

In	NULL
Epo-treated	NULL
cells	NULL
,	NULL
TALI	NULL
transcription	NULL
increased	NULL
a	NULL
mean	NULL
2.3-fold	NULL
within	NULL
1	NULL
h	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
growth	NULL
factor	NULL
and	NULL
remained	NULL
above	NULL
the	NULL
initial	NULL
level	NULL
for	NULL
at	NULL
least	NULL
4	NULL
h.	NULL
No	NULL
effect	NULL
of	NULL
Epo	NULL
was	NULL
seen	NULL
on	NULL
actin	NULL
transcription	NULL
in	NULL
the	NULL
first	NULL
4	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
measurements	NULL
of	NULL
actin	NULL
mRNA	NULL
levels	NULL
in	NULL
Epo-treated	NULL
FVA	NULL
cells	NULL
during	NULL
this	NULL
period	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Epo-stimulated	NULL
accumulation	NULL
of	NULL
TALI	NULL
message	NULL
results	NULL
in	NULL
part	NULL
from	NULL
an	NULL
increase	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Epo	NULL
Causes	NULL
Differential	NULL
Stabilization	NULL
of	NULL
TAL1	NULL
mRNA	NULL
Species	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-To	NULL
determine	NULL
whether	NULL
the	NULL
Epo-induced	NULL
increase	NULL
in	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
TALI	NULL
mRNAs	NULL
also	NULL
reflected	NULL
any	NULL
change	NULL
in	NULL
their	NULL
stability	NULL
,	NULL
TAL1	NULL
message	NULL
was	NULL
measured	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
cultures	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
at	NULL
a	NULL
concentration	NULL
previously	NULL
determined	NULL
to	NULL
inhibit	NULL
transcription	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
two	NULL
major	NULL
species	NULL
of	NULL
TALI	NULL
mRNA	NULL
,	NULL
which	NULL
diverge	NULL
in	NULL
their	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
and	NULL
utilize	NULL
different	NULL
polyadenylation	NULL
sites	NULL
(	NULL
42	NULL
)	NULL
,	NULL
were	NULL
found	NULL
to	NULL
have	NULL
different	NULL
half-lives	NULL
.	NULL

Treatment	NULL
of	NULL
FVA	NULL
cells	NULL
with	NULL
Epo	NULL
(	NULL
2	NULL
units/	NULL
ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
significantly	NULL
affected	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
decay	NULL
curve	NULL
of	NULL
the	NULL
5.0-kb	NULL
TAL	NULL
1	NULL
message	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
prolongation	NULL
in	NULL
the	NULL
calculated	NULL
half-life	NULL
from	NULL
approximately	NULL
2	NULL
to	NULL
3.5	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
stability	NULL
of	NULL
the	NULL
3.7-kb	NULL
message	NULL
was	NULL
unaltered	NULL
by	NULL
Epo	NULL
treatment	NULL
,	NULL
with	NULL
the	NULL
calculated	NULL
half-life	NULL
remaining	NULL
approximately	NULL
1	NULL
h	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Epo	NULL
.	NULL

Thus	NULL
,	NULL
RNA	NULL
stabilization	NULL
also	NULL
contributes	NULL
to	NULL
Epo-induced	NULL
accumulation	NULL
of	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
11606	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
3	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
transcription	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

FVA	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
Epo	NULL
g	NULL
p	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
h	NULL
and	NULL
nuclei	NULL
isolated	NULL
for	NULL
G	NULL
#	NULL
k	NULL
y	NULL
nuclear	NULL
run-off	NULL
analysis	NULL
as	NULL
described	NULL
un-	NULL
@	NULL
2-der	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Radiola-	NULL
8	NULL
beled	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
filters	NULL
to	NULL
2	NULL
which	NULL
plasmid	NULL
(	NULL
pGEM-4Z	NULL
)	NULL
and	NULL
TALI	NULL
and	NULL
G	NULL
actin	NULL
cDNAs	NULL
had	NULL
been	NULL
immobilized	NULL
,	NULL
and	NULL
LL	NULL
autoradiograms	NULL
of	NULL
hybridized	NULL
filters	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
.	NULL

Mean	NULL
induction	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
five	NULL
inde-	NULL
1-pendent	NULL
experiments	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
in	NULL
hours	NULL
after	NULL
Epo	NULL
addition	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
**	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
.	NULL

I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
100	NULL
so	NULL
-	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
stability	NULL
of	NULL
&	NULL
TAL1	NULL
mRNAs	NULL
in	NULL
FVA-induced	NULL
eryth-g	NULL
roblasts	NULL
.	NULL

FVA	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
fo	NULL
-	NULL
presence	NULL
(	NULL
BBI	NULL
,	NULL
®	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
L	NULL
]	NULL
,	NULL
O	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
2	NULL
GE	NULL
)	NULL
units/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
5	NULL
hs	NULL
ug/ml	NULL
actinomycin	NULL
D.	NULL
RNA	NULL
was	NULL
extracted	NULL
E	NULL
_	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
subjected	NULL
to	NULL
o	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Autoradiograms	NULL
[	NULL
OLD	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
scanning	NULL
densitometry	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
RNA	NULL
remaining	NULL
for	NULL
both	NULL
the	NULL
5.0-kb	NULL
(	NULL
O	NULL
,	NULL
@	NULL
)	NULL
and	NULL
+Epo	NULL
3.7-kb	NULL
(	NULL
C	NULL
,	NULL
®	NULL
)	NULL
TAL1	NULL
mRNAs	NULL
expressed	NULL
as	NULL
#	NULL
5.0	NULL
kb	NULL
a	NULL
function	NULL
of	NULL
time	NULL
following	NULL
addition	NULL
of	NULL
-	NULL
N	NULL
3.7	NULL
kb	NULL
actinomycin	NULL
D.	NULL
Data	NULL
represent	NULL
mean	NULL
-Epo	NULL
percent	NULL
*	NULL
S.E	NULL
.	NULL

from	NULL
four	NULL
independent	NULL
05.0	NULL
kb	NULL
experiments	NULL
.	NULL

03.7	NULL
kb	NULL
T	NULL
T	NULL
T	NULL
T	NULL
7T	NULL
T	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
180	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
TAL1	NULL
mRNA	NULL
in	NULL
Friend	NULL
virus-induced	NULL
erythroblasts	NULL
.	NULL

Epo	NULL
Increases	NULL
Nuclear	NULL
TAL1	NULL
Protein	NULL
Accumulation	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-Nuclear	NULL
TAL1	NULL
protein	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
using	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
generated	NULL
to	NULL
carboxyl-terminal	NULL
sequences	NULL
.	NULL

A	NULL
series	NULL
of	NULL
TAL1	NULL
proteins	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
45-47	NULL
kDa	NULL
increased	NULL
in	NULL
abundance	NULL
by	NULL
approximately	NULL
2-fold	NULL
as	NULL
determined	NULL
by	NULL
densitometry	NULL
in	NULL
Epo-treated	NULL
versus	NULL
Epo-deprived	NULL
cells	NULL
1-2	NULL
h	NULL
following	NULL
the	NULL
increase	NULL
in	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Another	NULL
TAL1	NULL
protein	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
24	NULL
kDa	NULL
was	NULL
expressed	NULL
transiently	NULL
in	NULL
Epo-stimulated	NULL
cells	NULL
,	NULL
peaking	NULL
at	NULL
2	NULL
h	NULL
and	NULL
then	NULL
largely	NULL
disappearing	NULL
by	NULL
4	NULL
h	NULL
after	NULL
growth	NULL
factor	NULL
addition	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
has	NULL
been	NULL
noted	NULL
in	NULL
T-lymphoid	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
erythroleukemia	NULL
cell	NULL
lines	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
although	NULL
it	NULL
has	NULL
not	NULL
previously	NULL
been	NULL
found	NULL
to	NULL
vary	NULL
in	NULL
expression	NULL
.	NULL

None	NULL
of	NULL
these	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
preimmune	NULL
immunoglobulin	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
masses	NULL
of	NULL
all	NULL
TAL1	NULL
species	NULL
,	NULL
particularly	NULL
the	NULL
truncated	NULL
form	NULL
,	NULL
were	NULL
different	NULL
in	NULL
FVA	NULL
than	NULL
in	NULL
COS	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
unique	NULL
or	NULL
more	NULL
extensive	NULL
modifications	NULL
of	NULL
the	NULL
proteins	NULL
occur	NULL
in	NULL
differentiating	NULL
erythroblasts	NULL
.	NULL

Epo	NULL
Stimulates	NULL
TAL1	NULL
DNA	NULL
Binding	NULL
Activity	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-Since	NULL
the	NULL
genomic	NULL
targets	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
are	NULL
not	NULL
yet	NULL
known	NULL
,	NULL
two	NULL
different	NULL
E-box	NULL
sequences	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

One	NULL
was	NULL
from	NULL
the	NULL
4E2	NULL
immunoglobulin	NULL
enhancer	NULL
,	NULL
to	NULL
which	NULL
TAL1	NULL
had	NULL
been	NULL
demonstrated	NULL
to	NULL
bind	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
the	NULL
E12	NULL
and	NULL
E47	NULL
protein	NULL
products	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
other	NULL
was	NULL
identified	NULL
by	NULL
a	NULL
site	NULL
selection	NULL
procedure	NULL
as	NULL
a	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
papeojumo	NULL
(	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
Hours	NULL
Epo	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
protein	NULL
accumulation	NULL
in	NULL
nuclei	NULL
of	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
FVA	NULL
cells	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
h.	NULL
Lane	NULL
marked	NULL
0	NULL
represents	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
prior	NULL
to	NULL
culture	NULL
,	NULL
COS	NULL
(	NULL
176	NULL
)	NULL
represents	NULL
nuclear	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
vector	NULL
(	NULL
peDNAI	NULL
)	NULL
containing	NULL
bases	NULL
490-1130	NULL
of	NULL
murine	NULL
TAL1	NULL
nucleotide	NULL
sequence	NULL
and	NULL
expressing	NULL
a	NULL
truncated	NULL
protein	NULL
initiating	NULL
at	NULL
Met-176	NULL
,	NULL
and	NULL
COS	NULL
(	NULL
1	NULL
)	NULL
represents	NULL
nuclear	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
expres-	NULL
B	NULL
sion	NULL
vector	NULL
containing	NULL
a	NULL
full-length	NULL
TALI	NULL
A	NULL
11607	NULL
--	NULL
'67	NULL
-	NULL
53	NULL
-	NULL
46	NULL
-	NULL
40	NULL
-	NULL
34	NULL
-	NULL
29	NULL
-	NULL
27	NULL
s	NULL
-21	NULL
cDNA	NULL
and	NULL
expressing	NULL
protein	NULL
from	NULL
Met-1	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
FVA	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
COS	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
fractionated	NULL
on	NULL
gradient	NULL
(	NULL
8-15	NULL
%	NULL
)	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Filters	NULL
were	NULL
probed	NULL
with	NULL
affinity-purified	NULL
anti-TAL1	NULL
antibody	NULL
and	NULL
binding	NULL
detected	NULL
by	NULL
enhanced	NULL
chemilumi-nescence	NULL
.	NULL

Sizes	NULL
of	NULL
protein	NULL
standards	NULL
run	NULL
in	NULL
parallel	NULL
are	NULL
given	NULL
in	NULL
kDa	NULL
.	NULL

B	NULL
,	NULL
composite	NULL
of	NULL
data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
relative	NULL
induction	NULL
+	NULL
S.E	NULL
.	NULL

expressed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
in	NULL
hours	NULL
following	NULL
Epo	NULL
addition	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
**	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
.	NULL

Relative	NULL
induction	NULL
preferred	NULL
sequence	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
uE2	NULL
oligonucleotide	NULL
,	NULL
a	NULL
TAL1-containing	NULL
protein-DNA	NULL
complex	NULL
was	NULL
noted	NULL
following	NULL
incubation	NULL
of	NULL
FVA	NULL
cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
arrowhead	NULL
,	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
that	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
unlabeled	NULL
competitor	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
with	NULL
the	NULL
use	NULL
of	NULL
a	NULL
radiolabeled	NULL
mutant	NULL
oligonucleotide	NULL
containing	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
E-box	NULL
motif	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
disrupted	NULL
by	NULL
anti-TAL1	NULL
antibody	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
preimmune	NULL
immunoglobulin	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
antibody	NULL
to	NULL
the	NULL
bHLH	NULL
protein	NULL
LYL-1	NULL
(	NULL
26	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
presence	NULL
of	NULL
TAL1	NULL
protein	NULL
in	NULL
the	NULL
retarded	NULL
complex	NULL
.	NULL

A	NULL
slightly	NULL
less	NULL
retarded	NULL
complex	NULL
was	NULL
also	NULL
noted	NULL
with	NULL
the	NULL
uE2	NULL
oligonucleotide	NULL
that	NULL
appeared	NULL
to	NULL
follow	NULL
the	NULL
same	NULL
kinetics	NULL
as	NULL
that	NULL
of	NULL
the	NULL
TAL1-containing	NULL
complex	NULL
.	NULL

It	NULL
was	NULL
similarly	NULL
ablated	NULL
by	NULL
excess	NULL
unlabeled	NULL
probe	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
TAL1-containing	NULL
complex	NULL
,	NULL
was	NULL
intensified	NULL
by	NULL
preincubation	NULL
of	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
extracts	NULL
with	NULL
anti-TAL1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
increased	NULL
within	NULL
1	NULL
h	NULL
of	NULL
addition	NULL
of	NULL
Epo	NULL
to	NULL
culture	NULL
but	NULL
declined	NULL
subsequently	NULL
despite	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
growth	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
activity	NULL
decreased	NULL
rapidly	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Epo	NULL
,	NULL
demonstrating	NULL
it	NULL
to	NULL
be	NULL
both	NULL
Epo-dependent	NULL
as	NULL
well	NULL
as	NULL
Epo-inducible	NULL
in	NULL
FVA	NULL
cell	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
TAL1-containing	NULL
protein-DNA	NULL
complex	NULL
was	NULL
also	NULL
identified	NULL
when	NULL
FVA	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
preferred	NULL
E-box	NULL
sequence	NULL
as	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Although	NULL
additional	NULL
complexes	NULL
were	NULL
noted	NULL
with	NULL
this	NULL
oligonucleotide	NULL
,	NULL
not	NULL
all	NULL
of	NULL
which	NULL
represented	NULL
sequence-specific	NULL
binding	NULL
,	NULL
only	NULL
the	NULL
most	NULL
retarded	NULL
band	NULL
was	NULL
affected	NULL
by	NULL
anti-TAL1	NULL
antibody	NULL
.	NULL

In	NULL
extracts	NULL
treated	NULL
with	NULL
antibody	NULL
,	NULL
this	NULL
TAL1-containing	NULL
complex	NULL
was	NULL
supershifted	NULL
to	NULL
the	NULL
extent	NULL
that	NULL
it	NULL
was	NULL
unable	NULL
to	NULL
enter	NULL
the	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
11608	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
A	NULL
B	NULL
C	NULL
Hours	NULL
Hours	NULL
1	NULL
g	NULL
5	NULL
1002	NULL
3	NULL
400	NULL
5006	NULL
0	NULL
403	NULL
50	NULL
24	NULL
Epo	NULL
o	NULL
l	NULL
0	NULL
4	NULL
10	NULL
4	NULL
%	NULL
G0	NULL
+	NULL
*	NULL
$	NULL
#	NULL
A	NULL
ea	NULL
O	NULL
tn	NULL
tn	NULL
on	NULL
f	NULL
f\	NULL
A	NULL
oe	NULL
@	NULL
y	NULL
on	NULL
do	NULL
Gn	NULL
aan	NULL
AW	NULL
WWb	NULL
)	NULL
|O	NULL
840|	NULL
clay	NULL
[	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
FVA	NULL
cells	NULL
incubated	NULL
under	NULL
the	NULL
indicated	NULL
conditions	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
uE2	NULL
immunoglobulin	NULL
enhancer	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
cultured	NULL
for	NULL
1	NULL
h	NULL
with	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
E2	NULL
probe	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
radiolabeled	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
unlabeled	NULL
competitor	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
radiolabeled	NULL
mutant	NULL
oligonucleotide	NULL
with	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
E-box	NULL
motif	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
antibody	NULL
to	NULL
murine	NULL
TAL1	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
preimmune	NULL
immunoglobulin	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
antibody	NULL
to	NULL
murine	NULL
LYL-1	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Specific	NULL
TAL1-containing	NULL
binding	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
arrowhead	NULL
.	NULL

B	NULL
,	NULL
equal	NULL
amounts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
prior	NULL
to	NULL
culture	NULL
(	NULL
0	NULL
)	NULL
and	NULL
after	NULL
incubation	NULL
for	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
24	NULL
h	NULL
with	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
uE2	NULL
probe	NULL
.	NULL

Specific	NULL
TAL1-containing	NULL
binding	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
arrowhead	NULL
.	NULL

C	NULL
,	NULL
equal	NULL
amounts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
cultured	NULL
in	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
for	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
h	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
E2	NULL
probe	NULL
.	NULL

Specific	NULL
TAL1-containing	NULL
binding	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
arrowhead	NULL
.	NULL

gel	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
assayed	NULL
with	NULL
the	NULL
preferred	NULL
sequence	NULL
was	NULL
generally	NULL
similar	NULL
to	NULL
that	NULL
noted	NULL
using	NULL
the	NULL
uE2	NULL
probe	NULL
,	NULL
except	NULL
that	NULL
peak	NULL
binding	NULL
activity	NULL
occurred	NULL
later	NULL
(	NULL
Figs	NULL
.	NULL

6B	NULL
and	NULL
7B	NULL
)	NULL
.	NULL

Epo	NULL
Stimulates	NULL
Nuclear	NULL
TAL1	NULL
Protein	NULL
Phosphorylation	NULL
in	NULL
FVA-induced	NULL
Erythroblasts-The	NULL
disparity	NULL
between	NULL
TAL1	NULL
protein	NULL
accumulation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
particularly	NULL
with	NULL
the	NULL
lower	NULL
affinity	NULL
uE2	NULL
probe	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
TAL1	NULL
protein	NULL
products	NULL
might	NULL
be	NULL
regulated	NULL
at	NULL
a	NULL
post-translational	NULL
level	NULL
in	NULL
Epo-treated	NULL
FVA	NULL
cells	NULL
.	NULL

As	NULL
TAL1	NULL
had	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
undergo	NULL
phosphorylation	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
43	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
protein	NULL
phosphorylation	NULL
was	NULL
analyzed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
labeled	NULL
with	NULL
[	NULL
*PJorthophosphate	NULL
.	NULL

A	NULL
47-kDa	NULL
nuclear	NULL
phosphoprotein	NULL
specifically	NULL
recognized	NULL
by	NULL
the	NULL
anti-TAL1	NULL
antibody	NULL
was	NULL
more	NULL
highly	NULL
labeled	NULL
in	NULL
Epo-treated	NULL
compared	NULL
with	NULL
Epo-deprived	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Two	NULL
radiolabeled	NULL
proteins	NULL
of	NULL
67	NULL
and	NULL
82	NULL
kDa	NULL
were	NULL
also	NULL
specifically	NULL
coimmunoprecipitated	NULL
with	NULL
TAL1	NULL
in	NULL
Epo-stimulated	NULL
FVA	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Time	NULL
course	NULL
studies	NULL
showed	NULL
that	NULL
phosphorylation	NULL
of	NULL
pp47	NULL
``	NULL
**	NULL
``	NULL
increased	NULL
within	NULL
1	NULL
h	NULL
of	NULL
growth	NULL
factor	NULL
addition	NULL
and	NULL
then	NULL
declined	NULL
over	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
,	NULL
with	NULL
equivalent	NULL
results	NULL
obtained	NULL
if	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
immunoprecipitation	NULL
by	NULL
trichloroacetic	NULL
acid-precipitable	NULL
counts	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
or	NULL
by	NULL
protein	NULL
concentration	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
restricted	NULL
to	NULL
a	NULL
nuclear	NULL
pool	NULL
of	NULL
TAL1	NULL
protein	NULL
in	NULL
that	NULL
no	NULL
net	NULL
increase	NULL
in	NULL
TAL1	NULL
phosphorylation	NULL
was	NULL
apparent	NULL
when	NULL
total	NULL
cellular	NULL
extracts	NULL
or	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
similarly	NULL
analyzed	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Studies	NULL
of	NULL
TALI	NULL
expression	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
gene	NULL
is	NULL
transcribed	NULL
in	NULL
erythroid	NULL
progenitors	NULL
and	NULL
suggested	NULL
its	NULL
protein	NULL
products	NULL
have	NULL
a	NULL
role	NULL
in	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Recently	NULL
,	NULL
Chiba	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
reported	NULL
that	NULL
Epo	NULL
could	NULL
induce	NULL
the	NULL
accumulation	NULL
of	NULL
TAL1	NULL
message	NULL
in	NULL
an	NULL
interleukin	NULL
3-dependent	NULL
cell	NULL
line	NULL
engineered	NULL
to	NULL
express	NULL
the	NULL
Epo	NULL
receptor	NULL
(	NULL
EpoR	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
using	NULL
bulk	NULL
populations	NULL
of	NULL
Friend	NULL
virus-induced	NULL
erythroblasts	NULL
demonstrate	NULL
that	NULL
TALI	NULL
transcription	NULL
is	NULL
an	NULL
early	NULL
response	NULL
to	NULL
Epo	NULL
stimulation	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
TALI	NULL
gene	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
growth	NULL
factor	NULL
's	NULL
signaling	NULL
mechanism	NULL
and	NULL
suggest	NULL
TAL1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
Epo	NULL
's	NULL
actions	NULL
on	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Like	NULL
those	NULL
of	NULL
hexamethylene	NULL
bisacetamide	NULL
and	NULL
Me	NULL
,	NULL
SO	NULL
on	NULL
MEL	NULL
lines	NULL
(	NULL
21	NULL
,	NULL
27	NULL
)	NULL
,	NULL
Epo	NULL
's	NULL
effects	NULL
in	NULL
cultured	NULL
FVA-induced	NULL
erythroblasts	NULL
were	NULL
on	NULL
cells	NULL
already	NULL
expressing	NULL
TALI	NULL
mRNA	NULL
and	NULL
protein	NULL
.	NULL

These	NULL
results	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
TALI	NULL
transcription	NULL
having	NULL
been	NULL
activated	NULL
at	NULL
some	NULL
earlier	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
49	NULL
)	NULL
and	NULL
then	NULL
later	NULL
becoming	NULL
Epo-responsive	NULL
,	NULL
with	NULL
either	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
ongoing	NULL
transcription	NULL
or	NULL
de	NULL
novo	NULL
activation	NULL
of	NULL
an	NULL
alternate	NULL
promoter	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

GATA-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transac-tivate	NULL
the	NULL
proximal	NULL
TAL	NULL
1	NULL
promoter	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
50	NULL
,	NULL
52	NULL
)	NULL
and	NULL
,	NULL
as	NULL
it	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
FVA	NULL
cells	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
Epo	NULL
,	NULL
could	NULL
contribute	NULL
to	NULL
this	NULL
basal	NULL
level	NULL
of	NULL
expression	NULL
.	NULL

Alternatively	NULL
,	NULL
spleen	NULL
focus-forming	NULL
virus-encoded	NULL
gp55	NULL
envelope	NULL
protein	NULL
,	NULL
whose	NULL
actions	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
membrane-displayed	NULL
EpoR	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
,	NULL
could	NULL
have	NULL
acted	NULL
in	NULL
an	NULL
Epo-independent	NULL
manner	NULL
to	NULL
stimulate	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
cultured	NULL
under	NULL
the	NULL
indicated	NULL
conditions	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
preferred	NULL
binding	NULL
sequence	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
FVA	NULL
cells	NULL
cultured	NULL
for	NULL
1	NULL
h	NULL
with	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
radiolabeled	NULL
mutant	NULL
oligonucleotide	NULL
with	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
E-box	NULL
motif	NULL
(	NULL
lanre	NULL
2	NULL
)	NULL
,	NULL
antibody	NULL
to	NULL
murine	NULL
TAL1	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
preimmune	NULL
immunoglobulin	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
antibody	NULL
to	NULL
murine	NULL
LYL-1	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

TAL1-containing	NULL
binding	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
arrowhead	NULL
.	NULL

B	NULL
,	NULL
equal	NULL
amounts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
FVA	NULL
cells	NULL
prior	NULL
to	NULL
culture	NULL
(	NULL
0	NULL
)	NULL
and	NULL
after	NULL
incubation	NULL
for	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
24	NULL
h	NULL
with	NULL
Epo	NULL
(	NULL
2	NULL
units/ml	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Specific	NULL
TAL1-containing	NULL
binding	NULL
complex	NULL
is	NULL
denoted	NULL
by	NULL
arrowhead	NULL
.	NULL

TAL1	NULL
transcription	NULL
.	NULL

Against	NULL
this	NULL
possibility	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
Epo-dependent	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
HCD-57	NULL
(	NULL
55	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
gp55	NULL
,	NULL
also	NULL
continues	NULL
to	NULL
express	NULL
TAL1	NULL
after	NULL
Epo	NULL
is	NULL
removed	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
to	NULL
any	NULL
effect	NULL
of	NULL
retroviral	NULL
proteins	NULL
,	NULL
heterogeneity	NULL
exists	NULL
in	NULL
FVA	NULL
cells	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
Epo	NULL
required	NULL
to	NULL
prevent	NULL
apoptosis	NULL
(	NULL
56	NULL
)	NULL
,	NULL
so	NULL
that	NULL
the	NULL
continued	NULL
expression	NULL
of	NULL
TALI	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
cultures	NULL
deprived	NULL
of	NULL
Epo	NULL
could	NULL
have	NULL
also	NULL
reflected	NULL
the	NULL
persistence	NULL
of	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
much	NULL
less	NULL
dependent	NULL
upon	NULL
the	NULL
growth	NULL
factor	NULL
for	NULL
survival	NULL
.	NULL

Whatever	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
component	NULL
of	NULL
Epo-independent	NULL
TALI	NULL
expression	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
an	NULL
Epo-induced	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
or	NULL
activity	NULL
of	NULL
the	NULL
TAL1	NULL
protein	NULL
products	NULL
may	NULL
be	NULL
required	NULL
for	NULL
completion	NULL
of	NULL
the	NULL
erythroid	NULL
differentiation	NULL
program	NULL
,	NULL
as	NULL
previously	NULL
suggested	NULL
for	NULL
GATA-1	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
TAL1	NULL
mRNA	NULL
in	NULL
Epo-treated	NULL
FVA	NULL
cells	NULL
was	NULL
followed	NULL
after	NULL
a	NULL
1-2	NULL
h	NULL
lag	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
*	NULL
K.	NULL
S.	NULL
S.	NULL
Prasad	NULL
,	NULL
J.	NULL
E.	NULL
Jordan	NULL
,	NULL
M.	NULL
J.	NULL
Koury	NULL
,	NULL
M.	NULL
C.	NULL
Bondurant	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Brandt	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

11609	NULL
A	NULL
-Epo	NULL
+Epo	NULL
--	NULL
o	NULL
--	NULL
Ab	NULL
-	NULL
Pre	NULL
Ab	NULL
_	NULL
Pre	NULL
124-	NULL
41.5-	NULL
Hours	NULL
Epo	NULL
124-	NULL
67	NULL
41.5-	NULL
30	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
Epo	NULL
on	NULL
TAL1	NULL
protein	NULL
phosphorylation	NULL
in	NULL
FVA-induced	NULL
erythroblasts	NULL
.	NULL

A	NULL
,	NULL
FVA	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
phosphate-free	NULL
medium	NULL
containing	NULL
[	NULL
*PJorthophosphate	NULL
(	NULL
0.9	NULL
mCi/ml	NULL
)	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
Epo	NULL
(	NULL
5	NULL
units/ml	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Equal	NULL
amounts	NULL
of	NULL
trichloroacetic	NULL
acid-precipitable	NULL
counts	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
were	NULL
immuno-precipitated	NULL
with	NULL
anti-TAL1	NULL
antibody	NULL
(	NULL
Ab	NULL
)	NULL
or	NULL
preimmune	NULL
immunoglobulin	NULL
(	NULL
Pre	NULL
)	NULL
and	NULL
immunoprecipitates	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

An	NULL
autoradiogram	NULL
of	NULL
the	NULL
dried	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
FVA	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
phosphate-free	NULL
medium	NULL
containing	NULL
[	NULL
*P	NULL
Jorthophosphate	NULL
(	NULL
0.5	NULL
mCi/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Epo	NULL
.	NULL

Epo	NULL
(	NULL
5	NULL
units/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
half	NULL
of	NULL
cultures	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
Epo	NULL
following	NULL
an	NULL
additional	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
h	NULL
in	NULL
culture	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
trichloroacetic	NULL
acid-precipitable	NULL
counts	NULL
(	NULL
540,000	NULL
cpm	NULL
)	NULL
from	NULL
each	NULL
extract	NULL
were	NULL
immu-noprecipitated	NULL
with	NULL
anti-TAL1	NULL
antibody	NULL
and	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

An	NULL
autoradiogram	NULL
of	NULL
dried	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

TAL1	NULL
and	NULL
coimmunoprecipitating	NULL
proteins	NULL
are	NULL
better	NULL
seen	NULL
in	NULL
autoradiogram	NULL
in	NULL
panel	NULL
A	NULL
than	NULL
B	NULL
because	NULL
of	NULL
the	NULL
greater	NULL
amount	NULL
of	NULL
label	NULL
added	NULL
to	NULL
cultures	NULL
and	NULL
greater	NULL
mass	NULL
of	NULL
protein	NULL
immunoprecipitated	NULL
.	NULL

full-length	NULL
protein	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
while	NULL
an	NULL
N-terminally	NULL
truncated	NULL
24-kDa	NULL
TAL1	NULL
protein	NULL
,	NULL
derived	NULL
from	NULL
a	NULL
series	NULL
of	NULL
spliced	NULL
RNAs	NULL
converging	NULL
on	NULL
the	NULL
second	NULL
coding	NULL
exon	NULL
(	NULL
43	NULL
)	NULL
,	NULL
was	NULL
only	NULL
transiently	NULL
expressed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Since	NULL
ribonuclease	NULL
protection	NULL
analysis	NULL
has	NULL
shown	NULL
that	NULL
at	NULL
least	NULL
one	NULL
RNA	NULL
species	NULL
from	NULL
which	NULL
this	NULL
protein	NULL
could	NULL
be	NULL
translated	NULL
is	NULL
highly	NULL
abundant	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
``	NULL
this	NULL
pattern	NULL
of	NULL
expression	NULL
suggests	NULL
that	NULL
either	NULL
its	NULL
stability	NULL
or	NULL
translation	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
Epo	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
splicing	NULL
,	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
found	NULL
in	NULL
the	NULL
full-length	NULL
protein	NULL
(	NULL
58	NULL
)	NULL
is	NULL
deleted	NULL
,	NULL
while	NULL
the	NULL
dimerization	NULL
and	NULL
DNA-binding	NULL
motifs	NULL
would	NULL
be	NULL
retained	NULL
.	NULL

Although	NULL
the	NULL
function	NULL
of	NULL
this	NULL
truncated	NULL
TAL1	NULL
species	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
,	NULL
there	NULL
exist	NULL
a	NULL
number	NULL
of	NULL
examples	NULL
of	NULL
transcriptional	NULL
repressors	NULL
and	NULL
activators	NULL
,	NULL
often	NULL
with	NULL
similarly	NULL
overlapping	NULL
patterns	NULL
of	NULL
expression	NULL
,	NULL
being	NULL
encoded	NULL
by	NULL
the	NULL
same	NULL
gene	NULL
as	NULL
a	NULL
result	NULL
of	NULL
alternative	NULL
splicing	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
11610	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

59	NULL
)	NULL
.	NULL

TAL1	NULL
DNA	NULL
binding	NULL
activity	NULL
increased	NULL
with	NULL
a	NULL
shorter	NULL
latency	NULL
in	NULL
Epo-stimulated	NULL
FVA	NULL
cells	NULL
than	NULL
predicted	NULL
by	NULL
the	NULL
more	NULL
delayed	NULL
increase	NULL
seen	NULL
in	NULL
TAL1	NULL
protein	NULL
levels	NULL
and	NULL
then	NULL
declined	NULL
even	NULL
while	NULL
mRNA	NULL
and	NULL
protein	NULL
accumulated	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
could	NULL
reflect	NULL
specific	NULL
modifications	NULL
of	NULL
TAL1	NULL
protein	NULL
,	NULL
the	NULL
availability	NULL
or	NULL
activity	NULL
of	NULL
its	NULL
dimerization	NULL
partners	NULL
,	NULL
changes	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
negative	NULL
regulators	NULL
,	NULL
or	NULL
any	NULL
combination	NULL
of	NULL
these	NULL
.	NULL

The	NULL
initial	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
correlated	NULL
temporally	NULL
with	NULL
the	NULL
accumulation	NULL
of	NULL
nuclear	NULL
TAL1	NULL
phosphoprotein	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
phosphorylation	NULL
might	NULL
regulate	NULL
this	NULL
function	NULL
.	NULL

Phosphorylation	NULL
is	NULL
known	NULL
to	NULL
affect	NULL
the	NULL
nuclear	NULL
uptake	NULL
,	NULL
affinity	NULL
and	NULL
specificity	NULL
of	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
activity	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
trangeription	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

60	NULL
)	NULL
,	NULL
and	NULL
its	NULL
effects	NULL
on	NULL
TAL1	NULL
function	NULL
may	NULL
well	NULL
be	NULL
multifactorial	NULL
.	NULL

Serine	NULL
122	NULL
of	NULL
TAL1	NULL
is	NULL
phosphorylated	NULL
by	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
ERK-1	NULL
in	NULL
leukemic	NULL
cell	NULL
lines	NULL
and	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
,	NULL
which	NULL
would	NULL
be	NULL
predicted	NULL
to	NULL
oceur	NULL
also	NULL
in	NULL
response	NULL
to	NULL
Epo	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
shown	NULL
recently	NULL
to	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
(	NULL
63	NULL
)	NULL
.	NULL

The	NULL
heterogeneity	NULL
seen	NULL
on	NULL
one-	NULL
and	NULL
two-dimensional	NULL
immunoblot	NULL
analysis	NULL
and	NULL
,	NULL
particularly	NULL
,	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
(	NULL
47	NULL
)	NULL
°	NULL
indicate	NULL
that	NULL
additional	NULL
sites	NULL
are	NULL
phosphorylated	NULL
and	NULL
suggest	NULL
the	NULL
TAL1	NULL
proteins	NULL
can	NULL
also	NULL
be	NULL
substrates	NULL
for	NULL
other	NULL
protein	NULL
kinases	NULL
.	NULL

The	NULL
results	NULL
of	NULL
phos-phoamino	NULL
acid	NULL
analysis	NULL
indicate	NULL
that	NULL
TAL1	NULL
phosphorylation	NULL
in	NULL
Friend	NULL
virus-induced	NULL
erythroblasts	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
leukemic	NULL
cell	NULL
lines	NULL
and	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
,	NULL
occurs	NULL
exclusively	NULL
on	NULL
serine	NULL
.	NULL
``	NULL

TAL1	NULL
,	NULL
like	NULL
other	NULL
tissue-specific	NULL
or	NULL
class	NULL
II	NULL
HLH	NULL
proteins	NULL
(	NULL
64	NULL
)	NULL
,	NULL
binds	NULL
DNA	NULL
as	NULL
a	NULL
heterodimer	NULL
,	NULL
so	NULL
that	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
might	NULL
also	NULL
be	NULL
regulated	NULL
indirectly	NULL
through	NULL
its	NULL
binding	NULL
partners	NULL
.	NULL

The	NULL
ultimate	NULL
decline	NULL
in	NULL
TAL1	NULL
E-box	NULL
binding	NULL
activity	NULL
in	NULL
Epo-treated	NULL
FVA	NULL
cells	NULL
,	NULL
then	NULL
,	NULL
could	NULL
potentially	NULL
be	NULL
explained	NULL
by	NULL
either	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
E	NULL
proteins	NULL
,	NULL
with	NULL
which	NULL
TAL1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
DNA	NULL
(	NULL
17	NULL
)	NULL
,	NULL
or	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
inhibitors	NULL
of	NULL
DNA	NULL
binding	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Id	NULL
proteins	NULL
.	NULL

Although	NULL
TAL1	NULL
was	NULL
reported	NULL
to	NULL
interact	NULL
only	NULL
weakly	NULL
with	NULL
Id1	NULL
and	NULL
Id2	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
,	NULL
Id1	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
E2A-TAL1	NULL
heterodimers	NULL
to	NULL
E-box	NULL
sequences	NULL
(	NULL
67	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
Id1	NULL
and	NULL
Id2	NULL
message	NULL
decline	NULL
with	NULL
differentiation	NULL
in	NULL
MEL	NULL
lines	NULL
(	NULL
35	NULL
,	NULL
65	NULL
,	NULL
66	NULL
)	NULL
,	NULL
however	NULL
,	NULL
and	NULL
Id1	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
at	NULL
the	NULL
sensitivity	NULL
of	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
FVA	NULL
cells	NULL
at	NULL
any	NULL
time	NULL
in	NULL
culture	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
accumulation	NULL
of	NULL
negative	NULL
regulators	NULL
to	NULL
be	NULL
a	NULL
less	NULL
likely	NULL
explanation	NULL
for	NULL
the	NULL
decline	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
observed	NULL
in	NULL
these	NULL
differentiating	NULL
erythroid	NULL
cells	NULL
.	NULL

Experiments	NULL
with	NULL
erythroleukemia	NULL
cell	NULL
lines	NULL
have	NULL
suggested	NULL
a	NULL
function	NULL
for	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
in	NULL
erythroid	NULL
differentiation	NULL
(	NULL
21	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
human	NULL
and	NULL
murine	NULL
erythroid	NULL
precursors	NULL
,	NULL
however	NULL
,	NULL
studies	NULL
at	NULL
the	NULL
resolution	NULL
of	NULL
the	NULL
single	NULL
cell	NULL
indicate	NULL
that	NULL
TAL1	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
become	NULL
progressively	NULL
down-regulated	NULL
with	NULL
terminal	NULL
differentiation	NULL
(	NULL
24	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
at	NULL
the	NULL
late	NULL
colony	NULL
forming	NULL
unit-erythroid	NULL
to	NULL
proerythroblast	NULL
stage	NULL
of	NULL
erythroid	NULL
differentiation	NULL
represented	NULL
by	NULL
FVA	NULL
cells	NULL
,	NULL
TAL	NULL
1	NULL
transcription	NULL
,	NULL
translation	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
are	NULL
,	NULL
at	NULL
least	NULL
initially	NULL
,	NULL
stimulated	NULL
by	NULL
Epo	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
actions	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
products	NULL
in	NULL
erythroid	NULL
differentiation	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
our	NULL
studies	NULL
establish	NULL
a	NULL
link	NULL
between	NULL
signaling	NULL
by	NULL
the	NULL
peptide	NULL
hormone	NULL
that	NULL
controls	NULL
the	NULL
terminal	NULL
events	NULL
of	NULL
erythropoiesis	NULL
and	NULL
a	NULL
member	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
family	NULL
involved	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
diverse	NULL
cell	NULL
lineages	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Robert	NULL
Benezra	NULL
for	NULL
the	NULL
Id	NULL
probe	NULL
,	NULL
Leonard	NULL
Zon	NULL
for	NULL
the	NULL
GATA-1	NULL
probe	NULL
,	NULL
Paul	NULL
Ney	NULL
for	NULL
advice	NULL
on	NULL
DNA	NULL
binding	NULL
assays	NULL
,	NULL
and	NULL
Amittha	NULL
Wickrema	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

14	NULL
,	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
,	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Erythropoietin	NULL
and	NULL
TAL1	NULL
{	NULL
/SCL	NULL
Expression	NULL
REFERENCES	NULL
.	NULL

Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Denning	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
10128-10132	NULL
.	NULL

Chen	NULL
,	NULL
Q.	NULL
,	NULL
Cheng	NULL
,	NULL
J.-T.	NULL
,	NULL
Tsai	NULL
,	NULL
L	NULL
-H.	NULL
,	NULL
Schneider	NULL
,	NULL
N.	NULL
,	NULL
Buchanan	NULL
,	NULL
G.	NULL
,	NULL
Carroll	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crist	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
415-424	NULL
.	NULL

Finger	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Kagan	NULL
,	NULL
J.	NULL
,	NULL
Christopher	NULL
,	NULL
G.	NULL
,	NULL
Kurtzberg	NULL
,	NULL
J.	NULL
,	NULL
Hershfield	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
50839-5043	NULL
.	NULL

Fitzgerald	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Neale	NULL
,	NULL
G.	NULL
A.	NULL
M.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Goorha	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
2686-2695	NULL
.	NULL

Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Lombardi	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Ginsberg	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Cossman	NULL
,	NULL
J.	NULL
,	NULL
Bertness	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
and	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
1426-1429	NULL
.	NULL

Brown	NULL
,	NULL
L.	NULL
,	NULL
Cheng	NULL
,	NULL
J.-T.	NULL
,	NULL
Chen	NULL
,	NULL
Q.	NULL
,	NULL
Siciliano	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Crist	NULL
,	NULL
W.	NULL
,	NULL
Buchanan	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3343-3851	NULL
.	NULL

Bernard	NULL
,	NULL
O.	NULL
,	NULL
Lecointe	NULL
,	NULL
N.	NULL
,	NULL
Jonveaux	NULL
,	NULL
P.	NULL
,	NULL
Souyri	NULL
,	NULL
M.	NULL
,	NULL
Mauchauffe	NULL
,	NULL
M.	NULL
,	NULL
Berger	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Larsen	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
1477-1488	NULL
.	NULL

Baer	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Cancer	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
341-347	NULL
.	NULL

Goldfarb	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Leuk	NULL
.	NULL

&	NULL
Lymphoma	NULL
12	NULL
,	NULL
157-166	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

Garrell	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Campuzano	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
BioEssays	NULL
18	NULL
,	NULL
493-498	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

4	NULL
,	NULL
49-55	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
777-783	NULL
Voronova	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
4722-4726	NULL
Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Cheng	NULL
,	NULL
P.-F.	NULL
,	NULL
Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
733-746	NULL
Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Wright	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Kadesch	NULL
,	NULL
T.	NULL
,	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
Voronova	NULL
,	NULL
A..	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
305-315	NULL
Hsu	NULL
,	NULL
H.-L.	NULL
,	NULL
Cheng	NULL
,	NULL
J.-T.	NULL
,	NULL
Chen	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3037-3042	NULL
Hsu	NULL
,	NULL
H.-L.	NULL
,	NULL
Wadman	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
3181-3185	NULL
Weintraub	NULL
,	NULL
H.	NULL
,	NULL
Tapscott	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Thayer	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Adam	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
5434-5438	NULL
Weintraub	NULL
,	NULL
H.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
,	NULL
Tapscott	NULL
,	NULL
S.	NULL
,	NULL
Thayer	NULL
,	NULL
M.	NULL
,	NULL
Krause	NULL
,	NULL
M.	NULL
,	NULL
Benezra	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
761-766	NULL
Quertermous	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Hidai	NULL
,	NULL
H.	NULL
,	NULL
Blanar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Quertermous	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
7066-7070	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Salvaris	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
475-479	NULL
Visvader	NULL
,	NULL
J.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Adams	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
187-194	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Lints	NULL
,	NULL
T.	NULL
,	NULL
Visvader	NULL
,	NULL
J.	NULL
,	NULL
Harvey	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
653-660	NULL
Mouthon	NULL
,	NULL
M.~A	NULL
.	NULL

,	NULL
Bernard	NULL
,	NULL
O.	NULL
,	NULL
Mitjavila	NULL
,	NULL
M.-T.	NULL
,	NULL
Romeo	NULL
,	NULL
P.-H.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Mathieu-Mahul	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
647-655	NULL
Hwang	NULL
,	NULL
L.-Y	NULL
.	NULL

,	NULL
Siegelman	NULL
,	NULL
M.	NULL
,	NULL
Davis	NULL
,	NULL
L.	NULL
,	NULL
Oppenheimer-Marks	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
3043-3046	NULL
Kallianpur	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Jordan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Brandt	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
1200-1208	NULL
Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Nakahara	NULL
,	NULL
K.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
4073-4081	NULL
Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
378-381	NULL
Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Sawyer	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1982	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

121	NULL
,	NULL
526-582	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Lind	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Ferguson	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
675-683	NULL
Koury	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
,	NULL
Cell	NULL
Biol	NULL
.	NULL

109	NULL
,	NULL
3005-3013	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Wickrema	NULL
,	NULL
A.	NULL
,	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Krantz	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
2269	NULL
2275	NULL
Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
Martin	NULL
,	NULL
D.	NULL
I	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
839	NULL
,	NULL
446-451	NULL
Benezra	NULL
,	NULL
R.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Lockshon	NULL
,	NULL
D.	NULL
,	NULL
Turner	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
{	NULL
1990	NULL
}	NULL
Cell	NULL
61	NULL
,	NULL
49-59	NULL
Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

182	NULL
,	NULL
6-13	NULL
Quinn	NULL
,	NULL
C.	NULL
O.	NULL
,	NULL
Scott	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Brinckerhoff	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Matrisian	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Jeffrey	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Partridge	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
22342-22344	NULL
Minty	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Caravatti	NULL
,	NULL
M.	NULL
,	NULL
Robert	NULL
,	NULL
B.	NULL
,	NULL
Cohen	NULL
,	NULL
A.	NULL
,	NULL
Daubas	NULL
,	NULL
P.	NULL
,	NULL
Weydert	NULL
,	NULL
A.	NULL
,	NULL
Gros	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Buckingham	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1981	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256	NULL
,	NULL
1008	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Lane	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Antibodies	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Visvader	NULL
,	NULL
J.	NULL
,	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
,	NULL
and	NULL
Gough	NULL
,	NULL
N.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
869-873	NULL
Cheng	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Hwang	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
677-683	NULL
Elwood	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Melder	NULL
,	NULL
A.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Nicola	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Leukemia	NULL
8	NULL
,	NULL
106-114	NULL
Hsu	NULL
,	NULL
H.-L.	NULL
,	NULL
Huang	NULL
,	NULL
L.	NULL
,	NULL
Tsan	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Funk	NULL
,	NULL
W.	NULL
,	NULL
Wright	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Hu	NULL
,	NULL
J.-S.	NULL
,	NULL
and	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1256-1265	NULL
Goldfarb	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Goueli	NULL
,	NULL
S.	NULL
,	NULL
Mickelson	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
2858-2866	NULL
Cheng	NULL
,	NULL
J.-T.	NULL
,	NULL
Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
801-808	NULL
Chiba	NULL
,	NULL
T.	NULL
,	NULL
Nagata	NULL
,	NULL
Y.	NULL
,	NULL
Kishi	NULL
,	NULL
A.	NULL
,	NULL
Sakamaki	NULL
,	NULL
K.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11598-11597	NULL
Cross	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Heyworth	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Murrell	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Bockamp	NULL
,	NULL
E.	NULL
O.	NULL
,	NULL
Dexter	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
3013-3016	NULL
Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Bertness	NULL
,	NULL
V.	NULL
,	NULL
Nussmeier	NULL
,	NULL
M.	NULL
,	NULL
Ezquerra	NULL
,	NULL
A.	NULL
,	NULL
Coligan	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Kirsch	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
6426-6435	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Robb	NULL
,	NULL
L.	NULL
,	NULL
Rockman	NULL
,	NULL
S.	NULL
,	NULL
Visvader	NULL
,	NULL
J.	NULL
,	NULL
Bockamp	NULL
,	NULL
E.	NULL
O.	NULL
,	NULL
Chan	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

188	NULL
,	NULL
93-99	NULL
Lecointe	NULL
,	NULL
N.	NULL
,	NULL
Bernard	NULL
,	NULL
O.	NULL
,	NULL
Naert	NULL
,	NULL
K.	NULL
,	NULL
Larsen	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Mathieu-	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
papeojumo	NULL
(	NULL
53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
,	NULL
61	NULL
.	NULL

Erythropoietin	NULL
and	NULL
TAL1/SCL	NULL
Expression	NULL
Mahul	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
2623-2632	NULL
D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Moreau	NULL
,	NULL
J.-F.	NULL
,	NULL
and	NULL
Showers	NULL
,	NULL
M.	NULL
O	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1114	NULL
,	NULL
31-41	NULL
Ferro	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kozak	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Hoatlin	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Kabat	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5741-5747	NULL
Spivak	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pham	NULL
,	NULL
T.	NULL
,	NULL
Isaacs	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hankins	NULL
,	NULL
W.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1228-1233	NULL
Kelley	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Koury	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Sawyer	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Wickrema	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
2340-2352	NULL
Leonard	NULL
,	NULL
M.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1071-1079	NULL
Sanchez-Garcia	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
7869-7873	NULL
Foulkes	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
and	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
411-414	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
375-387	NULL
Carroll	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Spivak	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
McMahon	NULL
,	NULL
M.	NULL
,	NULL
Weich	NULL
,	NULL
N.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
May	NULL
,	NULL
62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

11611	NULL
W.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14964-14969	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
X.-F.	NULL
,	NULL
and	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
279-283	NULL
Wadman	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
Hsu	NULL
,	NULL
H.-L.	NULL
,	NULL
Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Baer	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
3713-3716	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Vaessin	NULL
,	NULL
H.	NULL
,	NULL
Caudy	NULL
,	NULL
M.	NULL
,	NULL
Jan	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
Jan	NULL
,	NULL
Y.	NULL
N.	NULL
,	NULL
Cabrera	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Hauschka	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Weintraub	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
537-544	NULL
Sun	NULL
,	NULL
X.-H.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5603-5611	NULL
Shoji	NULL
,	NULL
W.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Obinata	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
5078-5084	NULL
Voronova	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
5952-5956	NULL
Warren	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Colledge	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Carlton	NULL
,	NULL
M.	NULL
B.	NULL
L.	NULL
,	NULL
Evans	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Smith	NULL
,	NULL
A.	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
45-57	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL
papeojumo	NULL
(	NULL
Erythropoietin	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
TAL1/SCL	NULL
gene	NULL
and	NULL
phosphorylation	NULL
of	NULL
its	NULL
protein	NULL
products	NULL
KS	NULL
Prasad	NULL
,	NULL
JE	NULL
Jordan	NULL
,	NULL
MJ	NULL
Koury	NULL
,	NULL
MC	NULL
Bondurant	NULL
and	NULL
SJ	NULL
Brandt	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:11603-11611.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.19.11603	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/19/11603	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
0	NULL
references	NULL
,	NULL
0	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
1603.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
wor	NULL
;	NULL

